A prospective randomized trial of one-week bismuth ranitidine citrate (RBC) triple therapies for H-pylori infection.

被引:0
|
作者
Sung, JJY
Chan, FKL
Leung, WK
Wu, JCY
Suen, R
Ling, TKW
Lee, YT
Cheng, AFB
Chung, SCS
机构
[1] Chinese Univ Hong Kong, Dept Microbiol, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong, Peoples R China
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
G1405
引用
收藏
页码:A321 / A321
页数:1
相关论文
共 50 条
  • [1] Randomized comparison of ranitidine bismuth citrate (RBC)-based triple therapies for H-pylori
    Laine, L
    Estrada, R
    Trujillo, M
    Emami, S
    [J]. GUT, 1997, 41 : A103 - A104
  • [2] Randomized comparison of ranitidine bismuth citrate (RBC)-based triple therapies for H-pylori (HP).
    Laine, L
    Estrada, R
    Trujillo, M
    Emami, S
    [J]. GASTROENTEROLOGY, 1997, 112 (04) : A192 - A192
  • [3] One-week therapy of ranitidine bismuth citrate (RBC) with different combinations of antimicrobial for H-pylori infection:: Which is the best regimen?
    Sung, JY
    Chan, FKL
    Leung, WK
    Wu, JCY
    Suen, R
    Ling, TKW
    Cheng, AFB
    Chung, SCS
    [J]. GUT, 1998, 43 : A81 - A81
  • [4] Prospective randomized comparisons of ranitidine bismuth citrate (RBC) versus colloidal bismuth subcitrate (Denol)-based triple therapy for the treatment of H-pylori infection.
    Kung, NNS
    Sung, JY
    Yuen, WF
    Li, TH
    Ng, PW
    Lai, WM
    Leung, MF
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A190 - A190
  • [5] High H-pylori eradication rate with a one week triple regimen containing ranitidine bismuth citrate (RBC)
    Gudjonsson, H
    Bardhan, KD
    Hoie, O
    Kristensen, ES
    Schuetz, E
    KliebeFrisch, C
    Duggan, AE
    [J]. GUT, 1997, 41 : A99 - A99
  • [6] One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection:: A randomized, clinical trial
    van der Wouden, EJ
    Thijs, JC
    van Zwet, AA
    Kooy, A
    Kleibeuker, JH
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (08): : 1228 - 1231
  • [7] One-week therapy with omeprazole or ranitidine bismuth citrate plus clarithromycin and and amoxicillin for treatment of Helicobacter pylori infection.
    Rojas, M
    Hergueta, P
    Romero, R
    Gomez, BJ
    Pellicer, FJ
    Herrerias, JM
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A1300 - A1300
  • [8] Ranitidine bismuth citrate (RBC) or omeprazole (O) with clarithromycin (C) and amoxycillin (A) for one week in the eradication of H-pylori
    Cabooter, M
    Dekkers, CPM
    Theodors, A
    Vanweerts, S
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A345 - A345
  • [9] One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese
    Hung, WK
    Wong, WM
    Wong, GSW
    Yip, AWC
    Szeto, ML
    Lai, KC
    Hu, WHC
    Chan, CK
    Xia, HHX
    Yuen, MF
    Fung, FMY
    Tong, TSM
    Ho, VYK
    Lam, SK
    Wong, BCY
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (12) : 2067 - 2072
  • [10] Metronidazole resistance does not influence the efficacy of triple therapy with ranitidine bismuth citrate (RBC), clarithromycin (CLA) and metronidazole (MET) for H-pylori (Hp) infection.
    van der Wouden, EJ
    Thijs, JC
    van Zwet, AA
    Kooy, A
    Kleibeuker, JH
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A323 - A323